INTERMEDICS THIRD-PARTY CERTIFICATION OF GMP COMPLIANCE
This article was originally published in The Gray Sheet
Executive SummaryINTERMEDICS THIRD-PARTY CERTIFICATION OF GMP COMPLIANCE is under way in response to a July 27 warning letter from FDA requesting the certification. The warning letter, which followed a March 7 to April 26 inspection of the company's pacemaker manufacturing facility in Angleton, Texas, cites the company's repeated deviations from good manufacturing practice regulations.
You may also be interested in...
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.